Non-invasive detection of actionable mutations in advanced non-small-cell lung cancer using targeted sequencing of circulating tumor DNA-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Non-invasive detection of actionable mutations in advanced non-small-cell lung cancer using targeted sequencing of circulating tumor DNA

Published:2018-10 Issue: Volume:124 Page:154-159
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Sim Wey Cheng,Loh Chet Hong,Toh Grace Li-Xian,Lim Chia Wei,Chopra Akhil^ORCID,Chang Alex Yuan Chi,Goh Liuh Ling

Funder

Singapore National Medical Research Council

QIAGEN liquid biopsy biomarker discovery and validation research grant

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference27 articles.

1. Non-Small-Cell Lung Cancer;National Comprehensive Cancer Network,2018

2. Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib;Eberhard;J. Clin. Oncol.,2005

3. Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer;Ludovini;J. Thorac. Oncol.,2011

4. Detection and dynamic changes of EGFR mutations from circulating tumor DNA as a predictor of survival outcomes in NSCLC patients treated with first-line intercalated erlotinib and chemotherapy;Mok;Clin. Cancer Res.,2015

5. Next generation sequencing techniques in liquid biopsy: focus on non-small cell lung cancer patients;Malapelle;Transl. Lung Cancer Res.,2016

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical application of ctDNA in early diagnosis, treatment and prognosis of patients with non-small cell lung cancer;Future Oncology;2024-07-29

2. The performance of homopolymer detection using dichromatic and tetrachromatic fluorogenic next-generation sequencing platforms;BMC Genomics;2024-05-31

3. Circulating biomarkers as predictors of response to immune checkpoint inhibitors in NSCLC: Are we on the right path?;Critical Reviews in Oncology/Hematology;2024-05

4. The changing face of circulating tumor DNA (ctDNA) profiling: Factors that shape the landscape of methodologies, technologies, and commercialization;Medizinische Genetik;2023-11-29

5. Applying Unique Molecular Indices with an Extensive All-in-One Forensic SNP Panel for Improved Genotype Accuracy and Sensitivity;Genes;2023-03-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3